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Colorectal cancers generally start as colorectal polyps, which can then develop through distinct 
pathways into colorectal cancer.  While the majority of colorectal cancers develop through the 
adenoma-carcinoma pathway, alternative pathways have also been identified.  One of these is the 
serrated pathway, a phenotypically distinct pathway travelled by a subset of colorectal 
cancers.  Genome-wide association studies have successfully identified genetic variants associated 
with colorectal cancer risk, but have not further explored whether these variants are also associated 
with particular subtypes of colorectal polyps.  In a recent report in The American Journal of 
Epidemiology, Drs. Andrea Burnett-Hartman and Karen Makar and colleagues in the Public Health 
Sciences Division tested the association between colorectal cancer risk loci and various polyp 
subtypes.  These associations were found to vary by subtype, suggesting that previously identified 
colorectal cancer risk loci play a role in early carcinogenesis for the adenoma-carcinoma pathway, 
rather than other pathways. 
To investigate these relationships, the authors utilized data collected on 1,800 Group Health 
Cooperative enrollees.  Tissue samples from clinical biopsies collected during colonoscopy were 
then classified by pathologists as one of six polyp types.  Participants were categorized into case 
and control groups based on having either adenomas, serrated polyps, both polyp types, or no 
identified polyps.  Participants were genotyped for thirteen single nucleotide polymorphisms (SNPs) 
previously identified as significantly associated with colorectal cancer.  These SNPs were then 
analyzed, both individually and as a combined risk-allele score, for an association with each of the 
polyp-type groups. 
Using this approach, the authors found that 5 of the 13 colorectal cancer SNPs were associated with 
polyps related to the adenoma-carcinoma pathway, and only one SNP was associated with the 
serrated pathway.  Similarly, the risk score analyses showed a significant per-allele association with 
adenomas, but not serrated polyps.  This suggests that across these 13 SNPs, increasing numbers 
of variant alleles raises colorectal cancer risk through the adenoma pathway but not the serrated 
pathway.  By considering lesion severity, the authors also found that more SNPs were associated 
with advanced than non-advanced adenomas, suggesting that these genetic variants were likely 
involved in cancer promotion rather than initiation.  Together, these results support the hypothesis 
that many of the variants previously identified for colorectal cancer risk are associated with early 
cancer-promoting events in the adenoma-carcinoma pathway.   
While the adenoma-carcinoma pathway accounts for roughly 75% of colorectal cancers, it is also 
important to characterize genetic variants that contribute to colorectal cancer risk through other 
pathways, such as the serrated pathway.  Given the results of this study, said lead author Burnett-
Hartman, "there are likely genetic variants that are important to the serrated pathway to colorectal 
cancer that have not yet been characterized".  Identifying these additional risk variants will help paint  
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a more accurate picture of how genetic variants impact the various pathways through which 
colorectal cancer is initiated and promoted, and ultimately should better characterize genetic risk for 
this disease.  This may be particularly important for pathways associated with later diagnosis and 
worse prognosis, such as the serrated pathway. 
To follow-up these findings, said Burnett-Hartman, "our future research will focus on identifying 
genetic loci that are specifically associated with colorectal cancers that develop via the serrated 
pathway."  For example, performing new genome-wide association studies in better-characterized 
colorectal cancer cases, which can then be analyzed by pathway or polyp type.  Such research 
should be a good step towards closing the knowledge gap between colorectal cancer subtypes, 
especially regarding the genetic mechanisms involved in subtypes with poor outcomes. 
Other PHS investigators contributing to this project were Drs. Polly Newcomb, Ulrike Peters, John 
Potter, and Karen Makar, as well as Mr. Michael Passarelli. 
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There are multiple pathways through which normal colon tissue can progress to colorectal cancer. 
 
